Biohub, the research organisation founded by Meta CEO Mark Zuckerberg and his wife Dr Priscilla Chan, has developed an AI model for protein research, which the company calls a “world model of protein biology”. The technology is expected to accelerate drug discovery. Biohub, the research organisation founded by Meta CEO Mark Zuckerberg and his wife Dr Priscilla Chan, has developed an AI model for protein research, which the company calls a “world model of protein biology”. The technology is expected to accelerate drug discovery.
Alex Rives, head of science at Biohub, said the system has learned to model biological processes so accurately that scientists can design protein binders on a computer and then validate their functionality in the lab.
“We have tested the model’s capabilities and confirmed many of its predictions, for example in immune diseases and cancer. This is very promising. We hope that researchers will quickly adopt it to solve the problems they face in the lab,” said Priscilla Chan.
Other companies are also developing AI models to support pharmaceutical research. For example, researchers at Google DeepMind have created an AI system that accelerates hypothesis generation, experimental testing and result analysis.